已收盤 02-06 16:00:00 美东时间
+0.320
+1.57%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
Piper Sandler analyst Manuel Navas reiterates Meridian (NASDAQ:MRBK) with a Overweight and raises the price target from $20 to $22.
02-04 01:43
Meridian Corporation (NASDAQ:MRBK) today reportedOn January 29, 2026, the Board of Directors declared a quarterly cash dividend of $0.14 per common share, payable February 17, 2026 to shareholders of record as
01-30 03:51
BRIEF-Meridian Corporation Q4 EPS USD 0.61 Jan 29 (Reuters) - Meridian Corporation Q4 dividend USD 0.14. Q4 net interest margin 3.77% Q4 revenue USD 12.6 million
01-30 03:49
Meridian Corp Q4 net income rises to USD 7.2 million Meridian Corporation reported net income of USD 7.2 million for the fourth quarter (Q4) ended December 31, 2025. Income before income taxes for the same period reached USD 25.0 million. The company’s efficiency ratio for Q4 2025 was 59 percent. No
01-30 02:37
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
2025-12-04 09:38
Piper Sandler analyst Manuel Navas assumes Meridian (NASDAQ:MRBK) with a Overweight rating and announces Price Target of $19.
2025-12-04 01:29
Meridian Bank (NASDAQ:MRBK) declares $0.125/share quarterly dividend, in line with previous. Forward yield 3.33% Payable Nov. 17; for shareholders of record Nov. 10; ex-div Nov. 10. See MRBK Dividend ...
2025-10-24 12:32
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
2025-07-30 09:36